0001832539-20-000001.txt : 20201117 0001832539-20-000001.hdr.sgml : 20201117 20201117113411 ACCESSION NUMBER: 0001832539-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201117 DATE AS OF CHANGE: 20201117 EFFECTIVENESS DATE: 20201117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Orphion Therapeutics, Inc. CENTRAL INDEX KEY: 0001832539 IRS NUMBER: 831675815 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380761 FILM NUMBER: 201319918 BUSINESS ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 BUSINESS PHONE: 9179515659 MAIL ADDRESS: STREET 1: 57 MEADOW WOODS ROAD CITY: GREAT NECK STATE: NY ZIP: 11020 D 1 primary_doc.xml X0708 D LIVE 0001832539 Orphion Therapeutics, Inc. 57 MEADOW WOODS ROAD GREAT NECK NY NEW YORK 11020 9179515659 DELAWARE None None Corporation true 2020 Jason Slakter c/o Orphion Therapeutics, Inc. 57 Meadow Woods Road Great Neck NY NEW YORK 11020 Executive Officer Director Michael Mashaal c/o Orphion Therapeutics, Inc. 57 Meadow Woods Road Great Neck NY NEW YORK 11020 Director Nickolay Voronin c/o Orphion Therapeutics, Inc. 57 Meadow Woods Road Great Neck NY NEW YORK 11020 Director Pharmaceuticals Decline to Disclose 06b false 2020-11-10 true true false 0 16332500 5332500 11000000 false 4 0 250000 true 0 false Orphion Therapeutics, Inc. Jason Slakter Jason Slakter Chief Executive Officer 2020-11-17